Opening setting
71%No trades yet. This is the uniform opening setting, not a community forecast.
Probability that the predicted event happens at all: all yes / by-a-date outcomes added together. “Other” is tracked as its own third slice.
Outcomes
Resolution criteria
A candidate for which Anthropic is the originator or sponsor enters a registered Phase 1. Resolution horizon: 2031-12-31. Source: ClinicalTrials.gov.
Evidence & context
Trials, publications and reports our research found on this prognosis. Each links to the original source.
This is a social post linking to a CNBC news report that Anthropic is starting an internal drug discovery program. It is indirect but relevant evidence because it indicates Anthropic is moving toward therapeutics R&D, which affects the likelihood and timing of eventually sponsoring a registered Phase 1 trial.